Ciloa is an exosome-based R&D power house that customize exosomes to contain any chosen proteins embedded in their membrane & inside their cytosol. Exosomes are naturally tailored in vivo by cells and membrane proteins complexes are sorted with their fully native conformation.
Natural properties of exosomes combined with Ciloa disruptive technology allow to develop I) antibodies against challenging targets; II) exosome-based therapeutic vectors; III) virus & adjuvant free vaccines